Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
ThredUp
TDUP
$407M
| $2.49M | ﹤0.01% |
331,847
+113,778
| +52% | +$669K |
|
2602
W&T Offshore
WTI
$555M
| $2.48M | ﹤0.01% |
1,500,375
+660,929
| +79% | +$974K |
|
2603
Arcturus Therapeutics
ARCT
$223M
| $2.47M | ﹤0.01% |
190,077
-4,552
| -2% | -$53.8K |
|
2604
Frontier Group Holdings
ULCC
$1.57B
| $2.47M | ﹤0.01% |
681,055
+112,231
| +20% | +$411K |
|
2605
Heron Therapeutics
HRTX
$66M
| $2.46M | ﹤0.01% |
1,186,120
+96,671
| +9% | +$197K |
|
|
ITOS
2606
DELISTED
iTeos Therapeutics
ITOS
| $2.45M | ﹤0.01% |
246,086
+12,525
| +5% | +$101K |
|
2607
International Money Express
IMXI
$344M
| $2.45M | ﹤0.01% |
242,555
-1,907
| -0.8% | -$21.8K |
|
|
SMC
2608
Summit Midstream
SMC
$483M
| $2.43M | ﹤0.01% |
99,049
+63,857
| +181% | +$1.75M |
|
2609
Schwab US Mid-Cap ETF
SCHM
$15.2B
| $2.43M | ﹤0.01% |
+86,532
| New | +$2.28M |
|
2610
CorMedix
CRMD
$566M
| $2.41M | ﹤0.01% |
195,455
+18,267
| +10% | +$202K |
|
2611
Fox Class B
FOX
$23.2B
| $2.41M | ﹤0.01% |
46,639
+3,513
| +8% | +$171K |
|
|
CDTX
2612
DELISTED
Cidara Therapeutics
CDTX
| $2.41M | ﹤0.01% |
+49,432
| New | +$1.19M |
|
|
OPRA
2613
Opera Ltd
OPRA
$1.78B
| $2.4M | ﹤0.01% |
126,918
-12,974
| -9% | -$222K |
|
|
CBLL
2614
CeriBell Inc
CBLL
$857M
| $2.4M | ﹤0.01% |
128,048
+31,995
| +33% | +$544K |
|
2615
HEICO Corp Class A
HEI.A
$37.6B
| $2.39M | ﹤0.01% |
9,235
+1,581
| +21% | +$346K |
|
2616
1-800-Flowers.com
FLWS
$258M
| $2.36M | ﹤0.01% |
479,246
+146,973
| +44% | +$761K |
|
2617
Microvision
MVIS
$113M
| $2.34M | ﹤0.01% |
136,941
+13,306
| +11% | +$230K |
|
2618
Advantage Solutions
ADV
$395M
| $2.32M | ﹤0.01% |
70,447
+28,515
| +68% | +$939K |
|
|
NNE
2619
Nano Nuclear Energy
NNE
$1.03B
| $2.32M | ﹤0.01% |
67,393
+8,102
| +14% | +$223K |
|
2620
Aveanna Healthcare
AVAH
$1.98B
| $2.32M | ﹤0.01% |
442,841
-11,778
| -3% | -$59.9K |
|
2621
STMicroelectronics
STM
$49.3B
| $2.31M | ﹤0.01% |
75,925
+13,052
| +21% | +$324K |
|
|
SPNS
2622
DELISTED
Sapiens International
SPNS
| $2.3M | ﹤0.01% |
78,687
+3,460
| +5% | +$96.4K |
|
2623
Atea Pharmaceuticals
AVIR
$410M
| $2.29M | ﹤0.01% |
635,282
+27,400
| +5% | +$81.7K |
|
2624
Savara
SVRA
$1.16B
| $2.27M | ﹤0.01% |
995,511
+40,681
| +4% | +$111K |
|
|
TBRG
2625
DELISTED
TruBridge
TBRG
| $2.27M | ﹤0.01% |
96,820
+25,248
| +35% | +$619K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.